Evaluate the Safety and Efficacy of AGE Serum in Post-menopausal Patients on Hormone Replacement Therapy Taking Glucagon-like Peptide-1 Agonist

The primary objective is to assess the safety and efficacy of the AGE Serum in improving the appearance of skin in post-menopausal subjects on HRT and non-HRT who are takingGLP-1 agonist therapy through the use of investigator assessments, subject questionnaires/assessments, photography, skin imaging, and reported adverse reactions.

NCT Number	NCT07558603
Lead Sponsor	Goldman, Butterwick, Fitzpatrick and Groff Collaborators: L'Oreal
Conditions	Laxity; Skin
Enrollment	50 participants
Start Date	2026-04-20
Primary Completion	2026-08-30 (estimated)
Study Completion	2026-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-04-30